Drug discovery > Target Discovery Products & Reviews

Products, services, reviews and techniques used in the identification and validation of the disease-causing target genes and proteins.

Product Filter

Drug discovery > Target Discovery
Browse by Techniques
Agilent Technologies

Ratings

Search

ABLE K Electroporation-Competent Cells

Agilent Technologies

The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold. 

0.0/5.0
|0 Reviews

AD-293 Cells

Agilent Technologies

The AdEasy system saves you a month of work over traditional methods by producing the recombinant adenoviral plasmid by homologous recombination in E. coli. 

0.0/5.0
|0 Reviews

ArcticExpress (DE3) Competent Cells

Agilent Technologies

ArcticExpress Competent Cells are engineered to address the common bacterial gene expression hurdle of protein insolubility. These cells are derived from the high-performance Stratagene BL21-Gold competent cells, enabling efficient high-level expression of heterologous proteins in E. coli.

0.0/5.0
|0 Reviews



ArcticExpress Competent Cells

Agilent Technologies

ArcticExpress Competent Cells are engineered to address the common bacterial gene expression hurdle of protein insolubility. These cells are derived from the high-performance Stratagene BL21-Gold competent cells, enabling efficient high-level expression of heterologous proteins in E. coli.

0.0/5.0
|0 Reviews



BacterioMatch II Electrocompetent Reporter Cells

Agilent Technologies

The exclusive BacterioMatch II two-hybrid system is an efficient method for detecting protein-protein interactions in vivo. The BacterioMatch II system offers the ability to screen libraries for harder-to-find binding partners with reduced background.  Fast results  Bacterial transformation - no new techniques to learn  Readily detect protein-protein interactions  Convenient dual reporter to validate putative positives…

0.0/5.0
|0 Reviews

BacterioMatch II Screening Reporter Competent Cells

Agilent Technologies

The exclusive BacterioMatch II two-hybrid system is an efficient method for detecting protein-protein interactions in vivo. The BacterioMatch II system offers the ability to screen libraries for harder-to-find binding partners with reduced background.  Fast results  Bacterial transformation - no new techniques to learn  Readily detect protein-protein interactions  Convenient dual reporter to validate putative positives…

0.0/5.0
|0 Reviews